Literature DB >> 32497716

Application of whole exome sequencing in detecting copy number variants in patients with developmental delay and/or multiple congenital malformations.

Évelin A Zanardo1, Fabíola P Monteiro2, Samar N Chehimi3, Yanca G Oliveira3, Alexandre T Dias3, Larissa A Costa2, Luiza L Ramos2, Gil M Novo-Filho3, Marília M Montenegro3, Amom M Nascimento3, João P Kitajima2, Fernando Kok4, Leslie D Kulikowski5.   

Abstract

Overcoming the challenges for the unambiguous detection of copy number variations is essential to broaden our understanding of the role of genomic variants in the clinical phenotype, in that sense, with the improvement of software and databases the whole exome sequencing can quickly become an excellent strategy in the routine diagnosis of patients with developmental delay and/or multiple congenital malformations. However, even after a detailed analysis of pathogenic single nucleotide variants and indels in known disease genes, using whole exome sequencing, some patients with suspected syndromic conditions are left without a conclusive diagnosis. These negative results could be due to different factors including non-genetic etiologies, lack of knowledge about the genes that cause different disease phenotypes, or in some cases a deletion or duplication of genomic information not routinely detectable by whole exome sequencing variant calling. While the copy number variants detection is possible using whole exome sequencing data, such analysis presents significant challenges and cannot yet be used to replace array in deletion or duplication identification.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Year:  2020        PMID: 32497716     DOI: 10.1016/j.jmoldx.2020.05.007

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  2 in total

Review 1.  Underlying genetic etiologies of congenital diaphragmatic hernia.

Authors:  Daryl A Scott; Yoel Gofin; Aliska M Berry; April D Adams
Journal:  Prenat Diagn       Date:  2022-01-22       Impact factor: 3.050

Review 2.  Clinical Exome Reanalysis: Current Practice and Beyond.

Authors:  Jianling Ji; Marco L Leung; Samuel Baker; Joshua L Deignan; Avni Santani
Journal:  Mol Diagn Ther       Date:  2021-07-20       Impact factor: 4.476

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.